SAB Biotherapeutics, Inc. - Common Stock, $0.0001 par value per share (SABS)
CUSIP: 78397T202
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 73,850,758
- Total 13F shares
- 36,342,111
- Share change
- +6,119,671
- Total reported value
- $135,919,535
- Price per share
- $3.74
- Number of holders
- 48
- Value change
- +$25,718,819
- Number of buys
- 31
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP 78397T202?
CUSIP 78397T202 identifies SABS - SAB Biotherapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q3 2025
Recent filing periods for CUSIP 78397T202:
Top shareholders of SABS - SAB Biotherapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. |
13D/G
|
— |
10%
|
25,931,000
|
$54,973,720 | $0 | 29 Sep 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
15%
|
11,420,000
|
$22,954,200 | — | 30 Sep 2025 | |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
|
BVF PARTNERS L P/IL |
9.1%
|
4,761,906
|
$18,761,910 | -$1,598,505 | 31 Dec 2025 | |
| Woodline Partners LP |
13D/G
13F
|
Company |
9.9%
|
7,125,881
|
$14,323,021 | $0 | 30 Sep 2025 | |
| Commodore Capital LP |
13D/G
13F
|
Company |
9.9%
|
4,522,977
|
$9,588,711 | $0 | 26 Sep 2025 | |
| Edward D. Hamilton |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
9,456,382
mixed-class rows
|
$9,348,396 | — | 22 Oct 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
6%
|
4,401,500
|
$8,847,015 | — | 30 Sep 2025 | |
| RTW INVESTMENTS, LP |
13D/G
|
— |
3.2%
|
1,587,302
|
$6,253,970 | +$2,218,090 | 31 Dec 2025 | |
| Sessa Capital IM, L.P. |
13F
|
Company |
3%
|
2,198,457
|
$4,418,899 | — | 30 Sep 2025 | |
| Andrew Moin |
3/4/5
|
Director |
—
mixed-class rows
|
2,523,807
mixed-class rows
|
$3,847,299 | — | 29 Sep 2025 | |
| Sessa Capital (Master), L.P. |
3/4/5
|
Director |
—
mixed-class rows
|
2,523,807
mixed-class rows
|
$3,847,299 | — | 29 Sep 2025 | |
| Ilan Katz |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
3,049,325
|
$2,683,406 | — | 13 Oct 2021 | |
| BVF INC/IL |
13F
|
Company |
1.3%
|
932,697
|
$1,874,721 | — | 30 Sep 2025 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.77%
|
566,395
|
$1,138,454 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.5%
|
365,753
|
$735,163 | — | 30 Sep 2025 | |
| HB Wealth Management, LLC |
13F
|
Company |
0.42%
|
307,500
|
$618,075 | — | 30 Sep 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.27%
|
200,000
|
$402,000 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
85,718
|
$172,317 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.11%
|
80,840
|
$162,488 | — | 30 Sep 2025 | |
| Pathstone Holdings, LLC |
13F
|
Company |
0.07%
|
50,650
|
$101,807 | — | 30 Sep 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.03%
|
19,982
|
$40,000 | — | 30 Sep 2025 | |
| Kovitz Investment Group Partners, LLC |
13F
|
Company |
0.03%
|
19,201
|
$38,594 | — | 30 Sep 2025 | |
| First PREMIER Bank |
13F
|
Company |
0.03%
|
18,986
|
$38,000 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
15,781
|
$31,720 | — | 30 Sep 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.02%
|
15,000
|
$30,150 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
—
mixed-class rows
|
36,635
mixed-class rows
|
$27,113 | — | 30 Sep 2025 | |
| Kestra Advisory Services, LLC |
13F
|
Company |
0.02%
|
11,930
|
$23,979 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
11,387
|
$22,888 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
11,221
|
$22,554 | — | 30 Sep 2025 | |
| CAXTON CORP |
13F
|
Company |
0.01%
|
10,935
|
$21,979 | — | 30 Sep 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.01%
|
6,339
|
$12,741 | — | 30 Sep 2025 | |
| LMR Partners LLP |
13F
|
Company |
—
class O/S missing
|
539,588
|
$12,626 | — | 30 Sep 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
4,824
|
$9,994 | — | 30 Sep 2025 | |
| Michael G. King Jr. |
3/4/5
|
CHIEF FINANCIAL OFFICER |
—
mixed-class rows
|
120,000
mixed-class rows
|
$4,400 | — | 21 Feb 2024 | |
| MORGAN STANLEY |
13F
|
Company |
—
mixed-class rows
|
146,607
mixed-class rows
|
$3,765 | — | 30 Sep 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,560
|
$3,136 | — | 30 Sep 2025 | |
| Clear Street Group Inc. |
13F
|
Company |
—
class O/S missing
|
79,033
|
$1,849 | — | 30 Sep 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
832
|
$1,672 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
—
class O/S missing
|
26,302
|
$750 | — | 30 Sep 2025 | |
| MAI Capital Management |
13F
|
Company |
0%
|
217
|
$437 | — | 30 Sep 2025 | |
| GS Investments, Inc. |
13F
|
Company |
0%
|
200
|
$402 | — | 30 Sep 2025 | |
| Walleye Trading LLC |
13F
|
Company |
—
class O/S missing
|
11,436
|
$268 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
87
|
$175 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
mixed-class rows
|
274
mixed-class rows
|
$154 | — | 30 Sep 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
52
|
$105 | — | 30 Sep 2025 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0%
|
50
|
$101 | — | 30 Sep 2025 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
—
class O/S missing
|
1,811
|
$42 | — | 30 Sep 2025 | |
| NewEdge Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
1,072
|
$25 | — | 30 Sep 2025 | |
| TORONTO DOMINION BANK |
13F
|
Company |
—
class O/S missing
|
200
|
$5 | — | 30 Sep 2025 | |
| Russell P. Beyer |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
275,000
|
— | — | 14 Mar 2023 |
Institutional Holders of SAB Biotherapeutics, Inc. - Common Stock, $0.0001 par value per share (SABS) as of Q4 2025
As of 31 Dec 2025,
SAB Biotherapeutics, Inc. - Common Stock, $0.0001 par value per share (SABS) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,342,111 shares.
The largest 10 holders included
Vivo Capital, LLC, Commodore Capital LP, RA CAPITAL MANAGEMENT, L.P., Woodline Partners LP, Spruce Street Capital LP, Sessa Capital IM, L.P., Blackstone Inc., VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, and Propel Bio Management, LLC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
34
Q4 2025 holders
48
Holder diff
14
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.